• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Allarity Therapeutics, Inc. - Common stock (NQ: ALLR )

    0.1829 +0.0062 (+3.51%)
    Streaming Delayed Price Updated: 3:59 PM EDT, Aug 23, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 2,801,662
    Open 0.1800
    Bid (Size) 0.1805 (40)
    Ask (Size) 0.1868 (220)
    Prev. Close 0.1767
    Today's Range 0.1755 - 0.2000
    52wk Range 0.1380 - 38.20
    Shares Outstanding 198,742,643
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    ALLARITY THERAPEUTICS, INC. ANNOUNCEMENT: If You Have Suffered Losses in Allarity Therapeutics, Inc. (NASDAQ: ALLR), You Are to Contact The Rosen Law Firm About Your Rights
    From The Rosen Law Firm PA
    Via GlobeNewswire
    ALLR Stock Earnings: Allarity Therapeutics Beats EPS for Q2 2024
    ALLR stock results show that Allarity Therapeutics beat analyst estimates for earnings per share the second quarter of 2024. 
    Via InvestorPlace

    Performance

    YTD
    -98.32%
    -98.32%
    1 Month
    +2.35%
    +2.35%
    3 Month
    -68.24%
    -68.24%
    6 Month
    -97.66%
    -97.66%
    1 Year
    -99.48%
    -99.48%

    More News

    Read More
    Allarity Therapeutics, Inc. (ALLR) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings
    From Bronstein, Gewirtz & Grossman, LLC
    Via Business Wire
    Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Continues Investigation of Allarity Therapeutics, Inc. (ALLR) on Behalf of Investors
    From Glancy Prongay & Murray LLP
    Via Business Wire
    INVESTOR ALERT: Law Offices of Howard G. Smith Continues Investigation of Allarity Therapeutics, Inc. (ALLR) on Behalf of Investors
    From Law Offices of Howard G. Smith
    Via Business Wire
    The Law Offices of Frank R. Cruz Continues Investigation of Allarity Therapeutics, Inc. (ALLR) on Behalf of Investors
    From The Law Offices of Frank R. Cruz
    Via Business Wire
    Allarity Therapeutics, Inc. (ALLR) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings
    From Bronstein, Gewirtz & Grossman, LLC
    Via Business Wire
    Allarity Therapeutics Announces Postponement of Annual Stockholders Meeting
    From Allarity Therapeutics, Inc.
    Via GlobeNewswire
    ALLR Investors Have Opportunity to Join Allarity Therapeutics, Inc. Securities Fraud Investigation with the Schall Law Firm
    From The Schall Law Firm
    Via Business Wire
    Rosen Law Firm Encourages Allarity Therapeutics, Inc. Investors to Inquire About Securities Class Action Investigation – ALLR
    From Rosen Law Firm
    Via Business Wire
    Why Are Chinese EV Stocks NIO, LI, XPEV Down Today?
    Via InvestorPlace
    Why General Dynamics Shares Are Trading Lower? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
    Via Benzinga
    ALLR Stock Alert: Allarity Therapeutics Pushes Shareholders to Back Reverse Split
    Via InvestorPlace
    Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Allarity Therapeutics, Inc. (ALLR) on Behalf of Investors
    From Glancy Prongay & Murray LLP
    Via Business Wire
    INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Allarity Therapeutics, Inc. (ALLR) on Behalf of Investors
    From Law Offices of Howard G. Smith
    Via Business Wire
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
    Via InvestorPlace
    Allarity Encourages Shareholders to Vote FOR the Reverse Stock Split and Decrease in Authorized Shares
    From Allarity Therapeutics, Inc.
    Via GlobeNewswire
    Why Enphase Energy Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket
    Via Benzinga
    The Law Offices of Frank R. Cruz Announces Investigation of Allarity Therapeutics, Inc. (ALLR) on Behalf of Investors
    From The Law Offices of Frank R. Cruz
    Via Business Wire
    Allarity Therapeutics Hit By SEC Notice Related Disclosures Of Once Lead Cancer Program
    Via Benzinga
    Topics Regulatory Compliance
    Exposures Legal Product Safety Regulatory
    Allarity Therapeutics Outlines Company’s 2024 Progress and Objectives
    From Allarity Therapeutics, Inc.
    Via GlobeNewswire
    Why ASLAN Pharmaceuticals Shares Are Trading Lower By Over 38%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
    Via Benzinga
    Allarity Granted Hearing Before Nasdaq Panel to Present Plan of Regaining Compliance
    From Allarity Therapeutics, Inc.
    Via GlobeNewswire
    Allarity Therapeutics’ Dual PARP/Tankyrase Inhibitor, Stenoparib, Continues to Show Extended Clinical Benefit in Advanced Ovarian Cancer
    From Allarity Therapeutics, Inc.
    Via GlobeNewswire
    Why Allarity Therapeutics (ALLR) Stock Is Getting Hammered
    Via Benzinga
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.